Tisha Mitsunaga, DrPH, ScM, discusses innovative approaches fostering collaboration between public health and healthcare facilities to combat multidrug-resistant organism (MDRO) spread.
Preventing the spread of multidrug-resistant organisms (MDROs) must be a collaborative effort between public health departments and health care facilities. However, how can that be done effectively?
Tisha Mitsunaga, DrPH, ScM, the Prevention Epidemiology Team Lead for the California Department of Public Health’s Healthcare-Associated Infections Program, Richmond, California, speaks with Infection Control Today® (ICT®) about her presentation on this topic.
She will give her presentation, “Prevention Collaboratives Involving Public Health Departments and Healthcare Facilities,” at the Society of Epidemiology of America in Houston, Texas, held from April 16 to 19, 2024.
ICT: What inspired you to choose the topics for your presentation at the SHEA conference this year?
Tisha Mitsunaga, DrPH, ScM: While the California Department of Health Healthcare-Associated Infections Program does a lot of great work with prevention activities across the state, I’m particularly proud of our regional multidrug-resistant organism (MDRO) prevention collaboratives that have used multidisciplinary and innovative approaches to engage health care facilities in this effort. This goes beyond education and training on infection prevention and control practices but also includes supporting antimicrobial stewardship and strengthening laboratory testing using peer-to-peer learning and convening hospitals and skilled nursing facilities (SNFs) in the same room to discuss challenges and opportunities to collaborate to address these challenges.
ICT: Could you elaborate on the key points or takeaways you aimed to deliver to the audience during your session?
TM: I’d like the audience to understand that health care facilities are part of a broader health care community, and therefore, it takes a village to prevent the spread of MDROs like Candida auris in health care settings. That is, public health, with the help of hospitals and nursing homes, can support a multipronged approach, including enhanced detection through clinical isolate testing and colonization screening, infection prevention and control (IPC), and antimicrobial stewardship activities. Communication plays a key role in stakeholder collaboration and coordination of these efforts.
Additionally, there are free public health resources to complement this approach, including webinars and other educational offerings, and laboratory testing services. One successful example of a partnership in practice is public health, which works with hospitals to implement screening patients for C auris upon admission. Through this process, hospitals have identified patients with C auris not previously known to be colonized, potentially preventing the spread at both the admitting and discharging facilities.
ICT: In your opinion, what are the most significant challenges that epidemiologists and other infection prevention personnel face today, and how does your presentation address these challenges?
TM: One challenge we face is being prepared to detect and respond to the next big health care-associated pathogen—today it might be C auris, but tomorrow it could be something new. I believe the principles behind the multi-pronged approach I lay out in the presentation can provide a great foundation for epidemiologists, infection prevention personnel, and other health care personnel to contain any new MDRO: robust surveillance systems; strong core infection prevention and control practices; antimicrobial stewardship programs; and communication, collaboration and coordination among public health and health care facilities can set us up to succeed now and in the future.
ICT: Do you have anything you’d like to add?
TM: I’d like to recognize all of my colleagues who have contributed to this effort and thank our health care partners for helping us prevent the spread of MDROs—we couldn’t do it without them. I’d also like to encourage all hospitals and SNFs to engage with and support their public health departments and take advantage of the free educational and testing resources available.
Resource:
Mitsunaga, T. Prevention Collaboratives Involving Public Health Departments and Healthcare Facilities.Poster was presented at SHEA 2024. April 16-19, 2024. Houston, TX.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies